Patterns of Physical Therapy Referral and Subsequent Attendance Among Childhood Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy at a Regional Childhood Cancer Survivorship Clinic

被引:0
|
作者
Kang, Lixin [1 ]
Kadan-Lottick, Nina S. [2 ]
Rotatori, Jaime [3 ]
Kujawski, Sophia E. [3 ]
Messerschmidt, Emily [4 ]
Auerbach, Claudia [3 ]
Balsamo, Lyn M. [3 ]
Lustberg, Maryam B. [5 ,7 ]
Ma, Xiaomei [1 ,6 ,7 ]
Rodwin, Rozalyn L. [3 ,7 ]
机构
[1] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA
[2] Georgetown Lombardi Comprehens Canc Ctr, Washington, DC USA
[3] Yale Sch Med, Dept Pediat, New Haven, CT USA
[4] Yale New Haven Hlth, Dept Rehabil Serv, New Haven, CT USA
[5] Yale Sch Med, Dept Med, New Haven, CT USA
[6] Yale Sch Med, Canc Outcomes Publ Policy & Effectiveness Res Ctr, New Haven, CT USA
[7] Yale Sch Med, Yale Canc Ctr, New Haven, CT USA
基金
美国国家卫生研究院;
关键词
Physical therapy; Childhood cancer survivor; Chemotherapy-induced peripheral neuropathy; Motor neuropathy; MAINTENANCE THERAPY; CHILDREN; CARE; NURSES; INTERVENTION; ADOLESCENTS; LEUKEMIA; ACCESS; IMPACT;
D O I
10.1016/j.soncn.2024.151716
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Childhood cancer survivors are at risk for chemotherapy-induced peripheral neuropathy (CIPN). Physical therapy (PT) improves CIPN symptoms, but little is known about survivors' PT utilization. We described characteristics of survivors with >= grade 2 CIPN, investigated PT referral and attendance, and described characteristics of survivors who attended and did not attend PT. Methods: Childhood cancer survivors <21 years old at cancer diagnosis and >= 2 years posttherapy, living in the United States, evaluated at a regional survivorship clinic were included in this retrospective analysis if they had motor CIPN. Symptomatic CIPN (>= grade 2 by Common Terminology Criteria for Adverse Events) and PT referral/attendance were tabulated. Patient characteristics from the medical record, and neighborhood characteristics (retrieved using survivors' zip code from the National Neighborhood Data Archive) were described by group. Results: Among 91 survivors with CIPN (median 17.5 years old, 8.1 years postcancer diagnosis, 45.1% female), 35 (38.5%) had >= grade 2 CIPN. Survivors with >= grade 2 CIPN were 28.6% female, and 45.7% were <13 years old. Twenty-four (68.6%) survivors with >= grade 2 CIPN agreed to PT referral, and 15 (42.9%) attended PT. Among survivors who attended PT, 73.3% were <13 years old. Neighborhood characteristics of survivors included median percentage of adults without a high school diploma (6.7% PT attendees, 12.5% nonattendees), median percentage of adults who are foreign-born (11.5% PT attendees, 16.4% nonattendees), and median percentage of households with an annual income of <$15,000 (3.2% PT attendees, 6.5% nonattendees). Conclusions: While 68.6% of survivors with >= grade 2 CIPN were referred to PT, only 42.9% attended. Studies to better understand barriers to PT attendance and interventions to improve attendance are needed, especially in older survivors.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] THE INFLUENCE OF CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY ON QUALITY OF LIFE OF GYNECOLOGIC CANCER SURVIVORS
    Matsuoka, H.
    Nakamura, K.
    Matsubara, Y.
    Ida, N.
    Saijo, M.
    Ogawa, C.
    Masuyama, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1002 - 1002
  • [22] Determining the impact of chemotherapy-induced peripheral neuropathy: A survey of cancer survivors.
    Battaglini, Eva
    Goldstein, David
    Park, Susanna
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
    McCrary, J. Matt
    Goldstein, David
    Sandler, Carolina X.
    Barry, Benjamin K.
    Marthick, Michael
    Timmins, Hannah C.
    Li, Tiffany
    Horvath, Lisa
    Grimison, Peter
    Park, Susanna B.
    SUPPORTIVE CARE IN CANCER, 2019, 27 (10) : 3849 - 3857
  • [24] Effect of chemotherapy-induced peripheral neuropathy on postural control in cancer survivors.
    Herman, Haley K.
    Monfort, Scott M.
    Pan, Xueliang Jeff
    Chaudhari, Ajit M. W.
    Lustberg, Maryam B.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
  • [25] DIFFERENCES IN THE SYMPTOM EXPERIENCE OF CANCER SURVIVORS WITH AND WITHOUT CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY
    Xu, Ling
    Kober, Kord
    Cooper, Bruce
    Paul, Steven
    Conley, Yvette
    Levine, Jon
    Miaskowski, Christine
    ONCOLOGY NURSING FORUM, 2022, 49 (02) : E169 - E169
  • [26] Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy
    J. Matt McCrary
    David Goldstein
    Carolina X. Sandler
    Benjamin K. Barry
    Michael Marthick
    Hannah C. Timmins
    Tiffany Li
    Lisa Horvath
    Peter Grimison
    Susanna B. Park
    Supportive Care in Cancer, 2019, 27 : 3849 - 3857
  • [27] DISTINCT SENSORY PROFILES IN CANCER SURVIVORS WITH CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY (CIPN)
    Mausisa, Grace
    Cooper, Bruce
    Paul, Steven
    Kober, Kord
    Miaskowski, Christine
    ONCOLOGY NURSING FORUM, 2020, 47 (02)
  • [28] Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort
    Kalyan Sreeram
    Randell Seaton
    Mark K. Greenwald
    Mandana Kamgar
    Hadeel Assad
    Tara Baird
    Ann G. Schwartz
    Julie Ruterbusch
    Michael S. Simon
    Cancer Causes & Control, 2023, 34 : 459 - 468
  • [29] Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes
    Kandula, Tejaswi
    Farrar, Michelle Anne
    Cohn, Richard J.
    Mizrahi, David
    Carey, Kate
    Johnston, Karen
    Kiernan, Matthew C.
    Krishnan, Arun V.
    Park, Susanna B.
    JAMA NEUROLOGY, 2018, 75 (08) : 980 - 988
  • [30] UPPER EXTERMITY CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY SYMPTOMS AMONG OLDER AND YOUNGER BREAST CANCER SURVIVORS
    Storey, Susan
    Cohee, Andrea
    Zanville, Noah
    Von Ah, Diane
    Champion, Victoria
    ONCOLOGY NURSING FORUM, 2020, 47 (02)